HK1075659A1 - A process for producing phenserine and its analog - Google Patents

A process for producing phenserine and its analog

Info

Publication number
HK1075659A1
HK1075659A1 HK05107730A HK05107730A HK1075659A1 HK 1075659 A1 HK1075659 A1 HK 1075659A1 HK 05107730 A HK05107730 A HK 05107730A HK 05107730 A HK05107730 A HK 05107730A HK 1075659 A1 HK1075659 A1 HK 1075659A1
Authority
HK
Hong Kong
Prior art keywords
phenserine
analog
producing
compounds
isocyanate
Prior art date
Application number
HK05107730A
Other languages
English (en)
Inventor
Joerg Bruening
Original Assignee
Axonyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc filed Critical Axonyx Inc
Publication of HK1075659A1 publication Critical patent/HK1075659A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK05107730A 2002-01-09 2005-09-02 A process for producing phenserine and its analog HK1075659A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/042,586 US6495700B1 (en) 2002-01-09 2002-01-09 Process for producing phenserine and its analog
PCT/US2002/039537 WO2003059909A1 (fr) 2002-01-09 2002-12-11 Processus de production de phenserine et de ses analogues

Publications (1)

Publication Number Publication Date
HK1075659A1 true HK1075659A1 (en) 2005-12-23

Family

ID=21922704

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107730A HK1075659A1 (en) 2002-01-09 2005-09-02 A process for producing phenserine and its analog

Country Status (16)

Country Link
US (1) US6495700B1 (fr)
EP (1) EP1463729B1 (fr)
JP (1) JP2005514459A (fr)
KR (2) KR20060097772A (fr)
CN (1) CN1301995C (fr)
AT (1) ATE466015T1 (fr)
AU (1) AU2002353102B2 (fr)
BR (1) BRPI0215492A2 (fr)
CA (1) CA2470560C (fr)
DE (1) DE60236207D1 (fr)
HK (1) HK1075659A1 (fr)
HR (1) HRP20040606A2 (fr)
HU (1) HUP0500747A3 (fr)
IL (1) IL162827A0 (fr)
PL (1) PL374240A1 (fr)
WO (1) WO2003059909A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897639B2 (en) 2003-10-21 2011-03-01 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
WO2006138385A2 (fr) * 2005-06-14 2006-12-28 Cancog Technologies Inc.24 Utilisation de la phenserine et de ses analogues pour traiter des troubles de comportement et ameliorer la capacite d'apprentissage
EP2275095A3 (fr) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
CA2789014C (fr) 2010-02-09 2019-01-15 Michela Gallagher Procedes et compositions pour ameliorer la fonction cognitive
US20120225922A1 (en) 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
WO2014078568A1 (fr) 2012-11-14 2014-05-22 The Johns Hopkins University Méthodes et compositions pour le traitement de la schizophrénie
EP3827820A1 (fr) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam pour améliorer la fonction cognitive
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam
AU2016309815B2 (en) 2015-08-14 2022-04-07 Annovis Bio, Inc. Methods of treatment or prevention of acute brain or nerve injuries
EP3654957A4 (fr) 2017-05-24 2021-06-23 Annovis Bio, Inc. Prévention ou traitement d'états pathologiques dus à une dys-homéostasie des métaux par administration de posiphène à des sujets humains sains ou malades

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US5306825A (en) 1984-03-01 1994-04-26 Consiglio Nazionale Delle Ricerche Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4791107A (en) 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US5187165A (en) 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US5260452A (en) 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5077289A (en) 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5177101A (en) 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5705657A (en) 1991-02-14 1998-01-06 Labochim Laboratorio Chimico Internazionale S.P.A. Isocyanate process for the preparation of 1,3A,8-trimethyl-1,2,3,3A, 8, 8A-hexahydro-pyrrole 2,3-B! indol-5 (3AS, 8AR) -hepthylcarbamate
EP0499959A1 (fr) 1991-02-18 1992-08-26 Bromine Compounds Ltd. Procédé pour la préparation des maléimides substitués
EP0606366B1 (fr) 1991-09-26 2003-06-04 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Phenserines et phenylcarbamates substitues de (-)-eseroline, (-)-n1-noreseroline, et (-)-n1-benzylnoreseroline utilises comme inhibiteurs specifiques de l'acetylcholinesterase
US5206260A (en) 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
FI933264A (fi) * 1992-07-21 1994-01-22 Hoechst Roussel Pharma Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
US5302721A (en) 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
US5409948A (en) 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers

Also Published As

Publication number Publication date
EP1463729A4 (fr) 2005-06-29
PL374240A1 (en) 2005-10-03
EP1463729B1 (fr) 2010-04-28
HRP20040606A2 (en) 2004-12-31
KR20040072711A (ko) 2004-08-18
HUP0500747A2 (hu) 2005-11-28
DE60236207D1 (de) 2010-06-10
CN1301995C (zh) 2007-02-28
IL162827A0 (en) 2005-11-20
CA2470560A1 (fr) 2003-07-24
JP2005514459A (ja) 2005-05-19
CN1612880A (zh) 2005-05-04
CA2470560C (fr) 2007-05-15
BRPI0215492A2 (pt) 2016-07-05
US6495700B1 (en) 2002-12-17
KR20060097772A (ko) 2006-09-15
HUP0500747A3 (en) 2009-05-28
EP1463729A1 (fr) 2004-10-06
KR100712003B1 (ko) 2007-05-02
AU2002353102B2 (en) 2007-05-24
ATE466015T1 (de) 2010-05-15
WO2003059909A1 (fr) 2003-07-24
AU2002353102A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
HK1075659A1 (en) A process for producing phenserine and its analog
RS59404A (en) Method for producing scopine esters
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
TNSN05105A1 (en) Novel bicyclic inhibitors of hormone sensitive lipase
HK1106518A1 (en) Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
IL175253A0 (en) A process for preparing pyrrole derivatives
GB0222056D0 (en) Process for the manufacture of organic compounds
MXPA04007396A (es) Proceso para la elaboracion de inhibidores de reductasa hmg-coa.
MXPA05008183A (es) Proceso para preparar pirrolotriazina como inhibidores de cinasa.
IL162817A0 (en) Process for the manufacture of organic compounds
WO2004043918A3 (fr) Nouvelles formes cristallines d'atorvastatine hemi-calcium et leurs procedes de preparation ainsi que de nouveaux procedes de preparation d'autres formes
GB0204129D0 (en) Process for the manufacture of organic compounds
MY145842A (en) Method of producing triethanolamine
TW200626606A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
TW200942546A (en) A crystalline form of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one
GB0210234D0 (en) Process for the manufacture of organic compounds
AU2003267565A8 (en) Process for the production of a fuel composition
WO2006043175A3 (fr) Procede de preparation de composes puriques
TW200624435A (en) Process for preparing iridium(Ⅲ) ketoketonates
GB0010475D0 (en) Organic compounds
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
WO2007096903A3 (fr) Nouvelle forme cristalline d'hemi-calcium d'atorvastatine
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
GB0320738D0 (en) Novel process

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101211